Results

Total Results: 382 records

Showing results for "minutes".

361. FRN 40 - Screening for Methicillin-Resistant Staphylococcus aureus (MRSA): Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mrsa-screening_research.pdf
     June 01, 2013 - In addition, a brief introductory call (30 minutes) was scheduled separately with each individual member

362. Supplemental Project To Assess the Transparency of Reporting Requirements for Studies Evaluating the Effectiveness of Treatment Options for Symptoms of Diabetic Peripheral Neuropathy (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/transparency-neuropathy_research.pdf
     March 01, 2018 - In this project, we estimate that it took 10 to 45 minutes per additional eligible study identified.

363. Angina-Heart-Attack-Treatments Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/angina-heart-attack-treatments_executive.pdf
     January 01, 2014 - cleavage, with approximately 20 percent being cleared by the kidneys, and has a plasma half-life of 25 minutes

364. PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/prostate-cancer-antigen-3-gene_research.pdf
     April 01, 2013 - PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs Future Research Needs Paper Number 24 PCA3 Testing in the Diagnosis and Management of Prostate Cancer: Future Research Needs Future Research Needs Paper Number 24 PCA3 Testing in the Diagnosis and Management of Prost…

365. Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/autism-interventions-future_research.pdf
     September 01, 2012 - Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders Future Research Needs Paper Number 20 Future Research Needs: Interventions for Adolescents and Young Adults With Autism Spectrum Disorders Future Research Needs Paper Number 20 Future Research Needs: I…

366. Future Research Needs for Diagnosis of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-diagnosis-future_research.pdf
     February 01, 2012 - Future Research Needs for Diagnosis of Obstructive Sleep Apnea Future Research Needs Paper Number 11 Future Research Needs for Diagnosis of Obstructive Sleep Apnea Future Research Needs Paper Number 11 Future Research Needs for Diagnosis of Obstructive Sleep Apnea Identification of Future Research …

367. Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/ptsd-adult-treatment_disposition-comments.pdf
     April 03, 2013 - Disposition of Comments for Psychological Treatments and Pharmacological Treatments for Adults With Posttraumatic Stress Disorder (PTSD) Comparative Effectiveness Research Review Disposition of Comments Report Research Review Title: Psychological Treatments and Pharmacological Treatments for Adults With Pos…

368. nnovative Methods in Stakeholder Engagement: An Environmental Scan (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/stakeholders-engagement-others_research-2012-1.pdf
     January 01, 2012 - nnovative Methods in Stakeholder Engagement: An Environmental Scan Innovative Methods in Stakeholder Engagement: An Environmental Scan Prepared for: Agency for Healthcare Research and Quality U.S. Department of Health and Human Services 540 Gaither Road Rockville, MD 20850 http://www.ahrq.g…

369. Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/vaccine-safety_disposition-comments.pdf
     January 01, 2020 - Disposition of Comments Report for Evidence Report 215 Safety of Vaccines Used for Routine Immunization in the United States Evidence Report/Technology Assessment Disposition of Comments Report Research Review Title: Safety of Vaccines Used for Routine Immunization in the United States Draft review avai…

370. Disposition of Comments for Comparative Effectiveness Review No. 240: Treatments for Acute Pain: A Systematic Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/cer-240-acute-pain-revised-comments.pdf
     December 29, 2020 - Document I tried NSAIDS, they did nothing for my pain (no relief at all), massages relief for 20 minutes

371. Disposition of Comments Report for Testing of CYP2C19 Variants and Platelet Reactivity for Guiding Antiplatelet Treatment (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/antiplatelet-treatment_disposition-comments.pdf
     September 25, 2013 - The assay is allowed to run for a period of time, usually 5‐8 minutes, and a tracing of % aggregation

372. Disposition of Comments for Efficacy and Safety of Screening for Postpartum Depression (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/depression-postpartum-screening_disposition-comments.pdf
     May 01, 2013 - Took me a few minutes to realize this was "Strength of Evidence".

373. Future Research Needs for Treatment of Obstructive Sleep Apnea (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/sleep-apnea-treatment-future_research.pdf
     February 01, 2012 - Future Research Needs for Treatment of Obstructive Sleep Apnea Future Research Needs Paper Number 12 Future Research Needs for Treatment of Obstructive Sleep Apnea Future Research Needs Paper Number 12 Future Research Needs for Treatment of Obstructive Sleep Apnea Identification of Future Research …

374. Microsoft Word - Comp Eff 10.doc (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
     January 01, 2007 - - Reduction of BP maximum at 60-90 minutes after oral administration, duration of effect dose-related

375. DRN: Report 1 (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/distributed-network-safety_research.pdf
     July 01, 2009 - approaches to dealing with delays / lags in query results across sites (some will get results in 2 minutes

376. Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/mat-retention-strategies-rapid-review-1.pdf
     August 01, 2020 - Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review Retention Strategies for Medications for Addiction Treatment in Adults With Opioid Use Disorder: A Rapid Evidence Review Rapid Evidence Product R Rapid Evidence Product Retention Strateg…

377. Renal-Function Executive (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/renal-function_executive.pdf
     August 01, 2014 - 1 Comparative Effectiveness Review Number 135 Cardiac Troponins Used as Diagnostic and Prognostic Tests in Patients With Kidney Disease Executive Summary Background Cardiac Troponin Assays Troponin Detection in Normal and Disease States Troponin is a protein complex of three subunits (T, I, and C) that is …

378. Dispostion of Comments Report for Screening for Hepatitis C Virus Infection in Adults (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/hepatitis-c-screening_disposition-comments.pdf
     November 27, 2012 - Unfortunately, the process for obtaining input from the Technical Expert Panel allowed several members a few minutes

379. Case Study Comparing Bayesian and Frequentist Approaches for Multiple Treatment Comparisons (pdf file)
     effectivehealthcare.ahrq.gov/sites/default/files/pdf/indirect-comparisons_research.pdf
     March 01, 2013 - incontinence episodes/day; >8 micturitions/day; >4 urgency episodes/day and mean warning time of <15 minutes

380. Cer-250-Cannabis-2024-Surv-Rep-Update-Tables-E1-4 (xls file)
     effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-2024-surv-rep-update-tables-e1-4.xlsx
     January 01, 2024 - E-1. Can. Study Characteristics Table E-1. Cannabis RCTs study characteristics PMID Author, Year Study Design Crossover Design Enriched Enrollment Randomized Withdrawal Design Setting Pain Population Pain Condition Prior Cannabis Exposure Age Measure (Mean, Median) Age, Years Female % Race, White % Race, Black % Race…